Sionna Therapeutics is trading at $7.10, up +5.19%, amid sharp recent volatility, with no confirmed company-specific catalyst identified.
- No new company-specific announcement for September 4, 2026, was identified in available coverage; the latest listed release is dated August 6, 2026.
- Gains on September 1–2 were followed by a 7.66% decline on September 3.
- Broader U.S. indices were lower, so market sentiment does not clearly explain the gain; monitoring is warranted.